What is the recommended daily dose of Vemlidy (tenofovir alafenamide)?

The recommended daily dose of Vemlidy (tenofovir alafenamide) is 25 mg. This dosage is established based on clinical studies that demonstrated its effectiveness while also considering the lower risk of renal side effects and bone mineral density loss compared to previous tenofovir formulations.

Tenofovir alafenamide is primarily used to treat chronic hepatitis B virus infections and has been selected for its favorable pharmacokinetic profile. When taken in the recommended dose, it achieves adequate antiviral activity while minimizing potential adverse effects. Understanding the proper dosing ensures optimal therapeutic outcomes and patient safety while managing the condition for which Vemlidy is prescribed.